Biomarkers of Alzheimer's disease: Bridging the gap between basic science and clinical practice
Small, D.H..
Journal of Alzheimer's Disease Jad 3(3): 257-259
2001
ISSN/ISBN: 1875-8908
PMID: 12214047
DOI: 10.3233/jad-2001-3301
Accession: 045379065
PDF emailed within 0-6 h: $19.90
Related References
D'Amelio, M.; Puglisi-Allegra, S.; Mercuri, N. 2018: The role of dopaminergic midbrain in Alzheimer's disease: Translating basic science into clinical practice Pharmacological Research 130: 414-419Mehić, B. 2012: Bridging between basic medical science and clinical practice Bosnian Journal of Basic Medical Sciences 12(1): 3
Rauch, S.L.; Savage, C.R. 1997: Neuroimaging and neuropsychology of the striatum. Bridging basic science and clinical practice Psychiatric Clinics of North America 20(4): 741-768
Kahn, K.; Ryan, G.; Beckett, M.; Taylor, S.; Berrebi, C.; Cho, M.; Quiter, E.; Fremont, A.; Pincus, H. 2011: Bridging the gap between basic science and clinical practice: a role for community clinicians Implementation Science: Is 6: 34
Meurer, S.K.; Alsamman, M.; Scholten, D.; Weiskirchen, R. 2014: Endoglin in liver fibrogenesis: Bridging basic science and clinical practice World Journal of Biological Chemistry 5(2): 180-203
Beckett, M.; Quiter, E.; Ryan, G.; Berrebi, C.; Taylor, S.; Cho, M.; Pincus, H.; Kahn, K. 2011: Bridging the gap between basic science and clinical practice: the role of organizations in addressing clinician barriers Implementation Science: Is 6: 35
Kliegman, R.M. 1990: Neonatal necrotizing enterocolitis: bridging the basic science with the clinical disease Journal of Pediatrics 117(5): 833-835
Dulewicz, M.; Kulczyńska-Przybik, A.; Mroczko, P.; Kornhuber, J.; Lewczuk, P.; Mroczko, B. 2022: Biomarkers for the Diagnosis of Alzheimer's Disease in Clinical Practice: the Role of CSF Biomarkers during the Evolution of Diagnostic Criteria International Journal of Molecular Sciences 23(15)
Downing, A.M.; Yaari, R.; Ball, D.E.; Selzler, K.J.; Devous, M.D. 2016: Bridging the Gap between Research and Clinical Practice in Asymptomatic Alzheimer's Disease Journal of Prevention of Alzheimer's Disease 3(1): 30-42
Koric, L.; Felician, O.; Ceccaldi, M. 2011: Utilisation des biomarqueurs du LCR dans le diagnostic de la maladie d'Alzheimer en pratique clinique - Use of CSF biomarkers in the diagnosis of Alzheimer's disease in clinical practice Revue Neurologique (Paris) 167(6-7): 474-484
Jones-Davis, D.M.; Buckholtz, N. 2015: The impact of the Alzheimer's Disease Neuroimaging Initiative 2: what role do public-private partnerships have in pushing the boundaries of clinical and basic science research on Alzheimer's disease? Alzheimer's and Dementia: the Journal of the Alzheimer's Association 11(7): 860-864
Rhodius-Meester, H.F.M.; Koikkalainen, J.; Mattila, J.; Teunissen, C.E.; Barkhof, F.; Lemstra, A.W.; Scheltens, P.; Lötjönen, J.; van der Flier, W.M. 2016: Integrating Biomarkers for Underlying Alzheimer's Disease in Mild Cognitive Impairment in Daily Practice: Comparison of a Clinical Decision Support System with Individual Biomarkers Journal of Alzheimer's Disease: Jad 50(1): 261-270
Taylor, J.C. 2003: Translational Genetics in Cardiovascular Disease and Cancer; bridging the gap between basic research and clinical practice American Journal of Human Genetics 73(5): 404
Pai, R. 2021: Advances in basic research in oncology in 2020: Bridging basic science and clinical care Indian Journal of Cancer 58(1): 28-29
Nagatsu, Toshiharu Toshi 2002: Molecular genetics of catecholamines Key molecules bridging basic science with clinical science Nagatsu, Toshiharu , Reprint Author, Nabeshima, Toshitaka, McCarty, Richard, Goldstein, David S Catecholamine research: From molecular insights to clinical medicine: 5-17
Koric, L.; Felician, O.; Ceccaldi, M. 2011: Use of CSF biomarkers in the diagnosis of Alzheimer's disease in clinical practice Revue Neurologique (Paris) 167(6-7): 474-484
Wyss-Coray, T.; Rogers, J. 2012: Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature Cold Spring Harbor Perspectives in Medicine 2(1): A006346
Petersen, R.C.; Trojanowski, J.Q. 2009: Use of Alzheimer disease biomarkers: potentially yes for clinical trials but not yet for clinical practice JAMA 302(4): 436-437
Vos, S.J.B.; Visser, P.J.; Verhey, F.; Aalten, P.; Knol, D.; Ramakers, I.; Scheltens, P.; Rikkert, M.G.M.O.; Verbeek, M.M.; Teunissen, C.E. 2014: Variability of CSF Alzheimer's disease biomarkers: implications for clinical practice Plos one 9(6): E100784
Ossenkoppele, R.; van der Kant, R.; Hansson, O. 2022: Tau biomarkers in Alzheimer's disease: towards implementation in clinical practice and trials LANCET. Neurology 21(8): 726-734